[go: up one dir, main page]

AU2001253479A1 - Targeted therapeutic agent release devices and methods of making and using the same - Google Patents

Targeted therapeutic agent release devices and methods of making and using the same

Info

Publication number
AU2001253479A1
AU2001253479A1 AU2001253479A AU5347901A AU2001253479A1 AU 2001253479 A1 AU2001253479 A1 AU 2001253479A1 AU 2001253479 A AU2001253479 A AU 2001253479A AU 5347901 A AU5347901 A AU 5347901A AU 2001253479 A1 AU2001253479 A1 AU 2001253479A1
Authority
AU
Australia
Prior art keywords
making
methods
same
therapeutic agent
release devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253479A
Other languages
English (en)
Inventor
Daniel Hullihen
Michael R. Violante
Frank Wang
Richard J. Whitbourne
Xianping Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biocoatings Corp
Original Assignee
STS Biopolymers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STS Biopolymers Inc filed Critical STS Biopolymers Inc
Publication of AU2001253479A1 publication Critical patent/AU2001253479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AU2001253479A 2000-04-13 2001-04-12 Targeted therapeutic agent release devices and methods of making and using the same Abandoned AU2001253479A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19678100P 2000-04-13 2000-04-13
US60196781 2000-04-13
PCT/US2001/012159 WO2001078626A1 (fr) 2000-04-13 2001-04-12 Dispositifs de liberation ciblee d'agents therapeutiques et procedes de fabrication et de mise en oeuvre de tels dispositifs

Publications (1)

Publication Number Publication Date
AU2001253479A1 true AU2001253479A1 (en) 2001-10-30

Family

ID=22726783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253479A Abandoned AU2001253479A1 (en) 2000-04-13 2001-04-12 Targeted therapeutic agent release devices and methods of making and using the same

Country Status (3)

Country Link
US (1) US8101200B2 (fr)
AU (1) AU2001253479A1 (fr)
WO (1) WO2001078626A1 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174157B1 (fr) 1998-04-27 2005-06-29 Surmodics Inc. Revêtement destiné à libérer des agents bioactifs
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
CA2484761C (fr) * 2002-05-24 2010-11-09 Angiotech International Ag Compositions et procedes d'enrobage d'implants medicaux
US8313760B2 (en) * 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US7097850B2 (en) * 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20030232087A1 (en) * 2002-06-18 2003-12-18 Lawin Laurie R. Bioactive agent release coating with aromatic poly(meth)acrylates
AU2003258206A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a polyurethane, medical device, and method
US20040115273A1 (en) * 2002-08-13 2004-06-17 Medtronic, Inc. Active agent delivery system including a hydrophobic cellulose derivative, medical device, and method
ATE459380T1 (de) * 2002-08-13 2010-03-15 Medtronic Inc Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren
JP2006502135A (ja) * 2002-08-13 2006-01-19 メドトロニック・インコーポレーテッド 活性薬剤デリバリーの、システム、医学用装置、及び方法
EP1534356B1 (fr) * 2002-08-13 2010-07-28 Medtronic, Inc. Dispositif medical assurant une meilleure adhesion entre un revetement polymere et un substrat
WO2004014448A1 (fr) * 2002-08-13 2004-02-19 Medtronic, Inc. Systeme d'administration d'agent actif comprenant un polymere hydrophile, dispositif medical et procede associe
EP1549253A4 (fr) * 2002-09-26 2010-11-03 Endovascular Devices Inc Appareil et procede de distribution de mitomycine au moyen d'un dispositif medical d'elution biocompatible implantable
AU2003301669B2 (en) * 2002-10-22 2009-04-30 Biomerix Corporation Method and system for intravesicular delivery of the therapeutic agents
JP4824549B2 (ja) 2003-05-02 2011-11-30 サーモディクス，インコーポレイティド 制御放出型の生体活性物質デリバリー・デバイス
US8246974B2 (en) * 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
EP1633275B1 (fr) 2003-05-15 2017-11-29 Biomerix Corporation Matrices elastomeres reticulees, leur production et leur utilisation dans des dispositifs implantables
CA2535346A1 (fr) * 2003-08-13 2005-03-03 Medtronic, Inc. Systemes de distribution d'agents actifs comprenant une seule couche d'un melange de polymeres miscibles, dispositifs medicaux et procedes
CA2535345A1 (fr) * 2003-08-13 2005-03-03 Medtronic, Inc. Systemes de distribution d'agents actifs comprenant un melange de polymeres miscibles, dispositifs medicaux et procedes
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
JP2007532187A (ja) * 2004-04-06 2007-11-15 サーモディクス，インコーポレイティド 生物活性物質のためのコーティング組成物
US20060083772A1 (en) * 2004-04-06 2006-04-20 Dewitt David M Coating compositions for bioactive agents
US20070190108A1 (en) * 2004-05-17 2007-08-16 Arindam Datta High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair
CA2586927A1 (fr) * 2004-11-09 2006-05-18 Angiotech Biocoatings Corp. Revetement d'aiguille antimicrobien pour perfusion prolongee
US20060116714A1 (en) * 2004-11-26 2006-06-01 Ivan Sepetka Coupling and release devices and methods for their assembly and use
US20060204533A1 (en) * 2005-03-14 2006-09-14 Biotegra, Inc. Drug Delivery Compositions and Related Methods
US11039942B2 (en) 2006-06-13 2021-06-22 Sino Medical Sciences Technology Inc. Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
US9884142B2 (en) * 2006-06-13 2018-02-06 Alchimedics Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US8685421B2 (en) * 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20080281350A1 (en) * 2006-12-13 2008-11-13 Biomerix Corporation Aneurysm Occlusion Devices
WO2008088537A2 (fr) 2006-12-20 2008-07-24 Boston Scientific Limited Stent pourvu d'un enrobage pour l'administration d'un agent thérapeutique
ATE551077T1 (de) * 2007-04-17 2012-04-15 Medtronic Inc Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung
DE102007039871A1 (de) * 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
EP2543399A3 (fr) * 2009-12-18 2013-07-10 Dentsply IH AB Dispositif médical pour une utilisation rapide avec un agent antibactérien rapidement libérable
CA2843641C (fr) * 2011-08-02 2017-03-28 3M Innovative Properties Company Article graphique
WO2013019699A2 (fr) 2011-08-02 2013-02-07 3M Innovative Properties Company Article graphique
CA2874824C (fr) 2012-06-01 2021-10-26 Surmodics, Inc. Appareil et methode de revetement de catheters a ballonnet
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
CA2888241C (fr) 2012-10-16 2020-12-29 Surmodics, Inc. Dispositif de pansement et procedes
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
CN104174074B (zh) * 2013-11-27 2016-05-18 浙江归创医疗器械有限公司 一种适用于涂在植入或介入医疗器械表面的药物涂层组合物
CN103736154B (zh) * 2013-12-26 2015-06-17 先健科技(深圳)有限公司 药物涂层球囊导管
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3209303A4 (fr) * 2014-10-24 2017-08-30 Avectas Limited Administration à travers des membranes plasmiques de cellules
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
GB201512030D0 (en) 2015-07-09 2015-08-19 Jmedtech Pte Ltd Composition
AU2016380836A1 (en) 2015-12-30 2018-07-12 Avectas Limited Vector-free delivery of gene editing proteins and compositions to cells and tissues
US11167064B2 (en) 2016-07-14 2021-11-09 Hollister Incorporated Hygienic medical devices having hydrophilic coating
WO2020112816A1 (fr) 2018-11-29 2020-06-04 Surmodics, Inc. Appareil et méthodes de revêtement de dispositifs médicaux
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
KR20220031858A (ko) * 2019-07-04 2022-03-14 에프. 호프만-라 로슈 아게 피하 삽입 가능한 요소를 신체 조직에 삽입하기 위한 이식 바늘
US12496612B2 (en) 2021-01-08 2025-12-16 Surmodics, Inc. Coating application system and methods for coating rotatable medical devices

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5001009A (en) 1987-09-02 1991-03-19 Sterilization Technical Services, Inc. Lubricious hydrophilic composite coated on substrates
US5069899A (en) * 1989-11-02 1991-12-03 Sterilization Technical Services, Inc. Anti-thrombogenic, anti-microbial compositions containing heparin
US5525348A (en) * 1989-11-02 1996-06-11 Sts Biopolymers, Inc. Coating compositions comprising pharmaceutical agents
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9314960D0 (en) 1992-07-23 1993-09-01 Zeneca Ltd Chemical compounds
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5523092A (en) * 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
PT711158E (pt) * 1993-07-29 2004-04-30 Us Gov Health & Human Serv Metodo para tratar aterosclerose ou restenose utilizando um agente de estabilizacao dos microtubulos
US5589120A (en) * 1994-08-22 1996-12-31 Becton Dickinson And Company Process of making a shaped tip on a catheter
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
AU704829B2 (en) 1994-12-28 1999-05-06 University Of Kentucky Murine anti-idiotype antibody 3H1
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5779673A (en) 1995-06-26 1998-07-14 Focal, Inc. Devices and methods for application of intraluminal photopolymerized gels
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
IL126179A (en) 1996-03-12 2003-04-10 Pg Txl Co Lp Pharmaceutical compositions containing anti-tumor drug conjugates
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US7070590B1 (en) * 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
US5800412A (en) 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
ATE279213T1 (de) 1996-11-06 2004-10-15 Sts Biopolymers Inc Beschichtung mit gasenthaltenden hohlräumen zur verstärkung von ultraschall-echos
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
IT1289815B1 (it) 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa Stent per angioplastica e relativo procedimento di produzione
US5997517A (en) * 1997-01-27 1999-12-07 Sts Biopolymers, Inc. Bonding layers for medical device surface coatings
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US6110483A (en) * 1997-06-23 2000-08-29 Sts Biopolymers, Inc. Adherent, flexible hydrogel and medicated coatings
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US5980550A (en) * 1998-06-18 1999-11-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US20010032011A1 (en) * 1999-07-20 2001-10-18 Stanford Ulf Harry Expandable stent with array of relief cuts
US20050283228A1 (en) * 1998-07-29 2005-12-22 Stanford Ulf H Expandable stent with relief holes capable of carrying medicines and other materials
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6293967B1 (en) * 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
EP1229901B1 (fr) * 1999-11-17 2009-03-18 Boston Scientific Limited Dispositifs microfabriques pour transport de molecules dans un fluide porteur
EP1132058A1 (fr) * 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Prothèse intravasculaire
US6395326B1 (en) * 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6254632B1 (en) * 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
DE60120955T3 (de) * 2001-07-20 2015-06-25 Cid S.P.A. Stent
WO2005049105A2 (fr) * 2003-11-10 2005-06-02 Angiotech International Ag Implants medicaux et agents anti-cicatrisation

Also Published As

Publication number Publication date
US20020018795A1 (en) 2002-02-14
US8101200B2 (en) 2012-01-24
WO2001078626A1 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001253479A1 (en) Targeted therapeutic agent release devices and methods of making and using the same
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002211389A1 (en) Microfluidic devices and methods of use
GB0415630D0 (en) Sustained release ophthalmological device and method of making and using the same
AU6118001A (en) Combination therapeutic compositions and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001280455A1 (en) Therapeutic device and system
AU2002327358A1 (en) Methods and devices for delivery of therapeutic capable agents with variable release profile
AU2002211276A1 (en) Selective coating of medical devices
AU2002356530A1 (en) Medical devices comprising nanomaterials and therapeutic methods utilizing the same
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU715620C (en) Therapeutic methods and uses
AU4848200A (en) Intravascular device and methods of manufacture and use
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002221273A1 (en) Delayed and sustained release formulations and method of use thereof
AU2002363800A1 (en) Therapeutic agent composition and method of use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001275696A1 (en) Therapeutic agent